DK148596C - Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK148596C
DK148596C DK358782A DK358782A DK148596C DK 148596 C DK148596 C DK 148596C DK 358782 A DK358782 A DK 358782A DK 358782 A DK358782 A DK 358782A DK 148596 C DK148596 C DK 148596C
Authority
DK
Denmark
Prior art keywords
analogue
amino
preparation
acid addition
addition salts
Prior art date
Application number
DK358782A
Other languages
Danish (da)
English (en)
Other versions
DK358782A (da
DK148596B (da
Inventor
Camille Georges Wermuth
Jean-Pierre Chambon
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK358782A publication Critical patent/DK358782A/da
Publication of DK148596B publication Critical patent/DK148596B/da
Application granted granted Critical
Publication of DK148596C publication Critical patent/DK148596C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK358782A 1981-08-11 1982-08-10 Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf DK148596C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8115546A FR2511366A1 (fr) 1981-08-11 1981-08-11 Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR8115546 1981-08-11

Publications (3)

Publication Number Publication Date
DK358782A DK358782A (da) 1983-02-12
DK148596B DK148596B (da) 1985-08-12
DK148596C true DK148596C (da) 1986-01-13

Family

ID=9261385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358782A DK148596C (da) 1981-08-11 1982-08-10 Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (30)

Country Link
US (1) US4710499A (es)
EP (1) EP0073161B1 (es)
JP (1) JPS5838263A (es)
KR (1) KR880002711B1 (es)
AR (1) AR231537A1 (es)
AT (1) ATE23042T1 (es)
AU (1) AU579570B2 (es)
CA (1) CA1179347A (es)
CS (1) CS239929B2 (es)
DD (1) DD202550A5 (es)
DE (1) DE3273893D1 (es)
DK (1) DK148596C (es)
EG (1) EG15749A (es)
ES (1) ES8305736A1 (es)
FI (1) FI72970C (es)
FR (1) FR2511366A1 (es)
GR (1) GR76236B (es)
HU (1) HU189608B (es)
IE (1) IE53493B1 (es)
IL (1) IL66424A (es)
MA (1) MA19559A1 (es)
NO (1) NO158871C (es)
NZ (1) NZ201553A (es)
OA (1) OA07179A (es)
PH (1) PH18921A (es)
PL (1) PL137200B1 (es)
PT (1) PT75372B (es)
SU (1) SU1356960A3 (es)
YU (1) YU171682A (es)
ZA (1) ZA825515B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
JPS60218377A (ja) * 1984-04-16 1985-11-01 Mitsubishi Yuka Yakuhin Kk 4−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
EP0628550B1 (en) 1993-06-08 1998-02-25 Sanofi Pyridazines as interleukin-1beta converting enzyme inhibitors
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
ES2543813T3 (es) 2004-11-02 2015-08-24 Northwestern University Compuestos de piridazina para el tratamiento de enfermedades inflamatorias
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
WO2007127375A2 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
JP2010520223A (ja) * 2007-03-02 2010-06-10 ノースウェスタン ユニバーシティ 発作関連障害のための組成物および方法
WO2024148148A1 (en) * 2023-01-04 2024-07-11 The Trustees Of Columbia University In The City Of New York Pyridazine based small molecule inhibitor of cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2473522A1 (fr) * 1980-01-16 1981-07-17 Synthelabo Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent

Also Published As

Publication number Publication date
EP0073161A1 (fr) 1983-03-02
JPS5838263A (ja) 1983-03-05
ZA825515B (en) 1983-06-29
YU171682A (en) 1985-03-20
AU8702982A (en) 1983-05-12
NO158871C (no) 1988-11-09
US4710499A (en) 1987-12-01
NO822717L (no) 1983-02-14
FI822768A0 (fi) 1982-08-09
HU189608B (en) 1986-07-28
EG15749A (en) 1986-09-30
FR2511366A1 (fr) 1983-02-18
FR2511366B1 (es) 1984-12-14
IE53493B1 (en) 1988-11-23
PL237836A1 (en) 1983-02-28
AR231537A1 (es) 1984-12-28
PT75372A (en) 1982-09-01
JPH0456032B2 (es) 1992-09-07
SU1356960A3 (ru) 1987-11-30
EP0073161B1 (fr) 1986-10-22
IL66424A (en) 1985-10-31
DK358782A (da) 1983-02-12
PH18921A (en) 1985-11-11
NZ201553A (en) 1985-08-16
KR880002711B1 (ko) 1988-12-26
CS239929B2 (en) 1986-01-16
ES514887A0 (es) 1983-04-16
FI822768L (fi) 1983-02-11
CA1179347A (en) 1984-12-11
DK148596B (da) 1985-08-12
GR76236B (es) 1984-08-04
KR840001147A (ko) 1984-03-28
IE821822L (en) 1983-02-11
FI72970B (fi) 1987-04-30
IL66424A0 (en) 1982-11-30
OA07179A (fr) 1984-04-30
NO158871B (no) 1988-08-01
DE3273893D1 (en) 1986-11-27
DD202550A5 (de) 1983-09-21
ES8305736A1 (es) 1983-04-16
AU579570B2 (en) 1988-12-01
PL137200B1 (en) 1986-05-31
FI72970C (fi) 1987-08-10
ATE23042T1 (de) 1986-11-15
MA19559A1 (fr) 1983-04-01
PT75372B (en) 1984-12-10

Similar Documents

Publication Publication Date Title
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK156720C (da) Analogifremgangsmaade til fremstilling af benzazepinderivater eller fysiologisk acceptable syreadditionssalte deraf
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK148795C (da) Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf
DK149630C (da) Analogifremgangsmaade til fremstilling af tripeptidamider eller -estere eller fysiologisk acceptable syreadditionssalte deraf
DK148596C (da) Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK158983C (da) Analogifremgangsmaade til fremstilling af benzoylpiperazinestre eller syreadditionssalte deraf
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK160498C (da) Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf
DK149841C (da) Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148903C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf
DK144793C (da) Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK160875C (da) Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK151021C (da) Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf
DK149750C (da) Analogifremgangsmaade til fremstilling af n-alkenylmoranolin-derivater eller farmaceutiske acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed